Medical School
Baylor College of Medicine (1996)
Baylor College of Medicine (1999), Internal Medicine
UT Southwestern Medical Center (2002), Infectious Diseases
Other Post Graduate Training
University of Texas Health Science Center at Dallas (2004)
Graduate School
University of Texas Health Science Center at Dallas (2004), Public Health

Research Interest

  • Hepatitis B
  • Hepatitis C
  • HIV and complications
  • HIV and Liver Disease
  • Influenza
  • Viral Eradication


Featured Publications LegendFeatured Publications

A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.
Yuan H, Adams-Huet B, Petersen T, Attar N, Lee WM, Jain MK J. Med. Virol. 2012 Dec 84 12 1913-9
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.
Yopp AC, Subramanian M, Jain MK, Mansour JC, Schwarz RE, Balch GC, Singal AG Clin. Gastroenterol. Hepatol. 2012 Nov 10 11 1284-90
Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM AIDS Patient Care STDS 2012 Feb 26 2 73-80
Hepatitis B virus genotype G: Prevalence and impact in patients co-infected with human immunodeficiency virus.
Dao DY, Balko J, Attar N, Neak E, Yuan HJ, Lee WM, Jain MK J. Med. Virol. 2011 Sep 83 9 1551-8
Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.
Ibarra KD, Jain MK, Pfeiffer JK J. Virol. 2011 Jul 85 14 7273-83
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*.
Yuan HJ, Jain M, Snow KK, Gale M, Lee WM J. Viral Hepat. 2010 Mar 17 3 208-16
Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment.
Jain MK, Yuan HJ, Adams-Huet B, Reeck A, Shelton J, Attar N, Zhang S, Neumann AU, Carney DS, Gale M, Lee WM J. Infect. Dis. 2009 Sep 200 6 866-76
Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques.
Kosub DA, Durudas A, Lehrman G, Milush JM, Cano CA, Jain MK, Sodora DL Curr. HIV Res. 2008 Nov 6 6 520-30
Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.
Kosub DA, Lehrman G, Milush JM, Zhou D, Chacko E, Leone A, Gordon S, Silvestri G, Else JG, Keiser P, Jain MK, Sodora DL, J. Virol. 2008 Feb 82 3 1155-65
Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.
Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, Vardhineni K, Lee WM HIV Med. 2007 Nov 8 8 491-7

Honors & Awards

  • Fellow of Infectious Disease Society of America
  • Best Doctors in Dallas "D Magazine"
  • K23 NIH Grant
  • Student Research Grant
  • Training Award
    Patient Oriented Research (2001)
  • Travel Grant Award
    Outstanding Abstract Submission, IDSA (2001)

Professional Associations/Affiliations

  • Texas Infectious Disease Society (2018)
  • Infectious Disease Society of America, Fellow (2015)
  • American Association for the Study of Liver Disease (2003)
  • Infectious Disease Society of America (2002)